Related references
Note: Only part of the references are listed.An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose Homeostasis
Laurie L. Baggio et al.
GASTROENTEROLOGY (2008)
Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride
Ananda Basu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans
C. N. Andrews et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans
JJ Meier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans
N. Charkoudian et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
A possible role of GLP-1 in the pathophysiology of early dumping syndrome
H Yamamoto et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy
LA Nikolaidis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation
N Charkoudian et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome
NM Swift et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Investigation of the mechanisms involved in the central effects of glucagon-like peptide-1 on ethanol-induced gastric mucosal lesions
N Isbil-Buyukcoskun et al.
REGULATORY PEPTIDES (2005)
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism
T Nyström et al.
REGULATORY PEPTIDES (2005)
Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study
GA Suarez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion
LA Nikolaidis et al.
CIRCULATION (2004)
Catecholamine metabolism: A contemporary view with implications for physiology and medicine
G Eisenhofer et al.
PHARMACOLOGICAL REVIEWS (2004)
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
T Nyström et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes
JJ Meier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans
J Tack et al.
GUT (2002)
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study
M Zander et al.
LANCET (2002)
Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
AJ Kastin et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Nitric oxide and cardiac autonomic control in humans
S Chowdhary et al.
HYPERTENSION (2000)
Effects of glucagon-like peptide-1 (7-36) amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans
J Schirra et al.
GUT (2000)
Share Paper
